Relation between acanthosis nigricans and insulin sensitivity in overweight Hispanic children at risk for type 2

Hassan A Kobaissi1, Marc J Weigensberg, Geoff D C Ball

  • 1Department of Preventive Medicine, Keck School of Medicine, University of Southern California Health Sciences Campus, 1540 Alcazar Street, Rm. 208-D, Los Angeles, CA 90033, USA.

Diabetes Care
|May 27, 2004
PubMed

Insights

Acanthosis nigricans (AN) is an independent risk factor for insulin resistance in overweight Hispanic children. However, body adiposity remains the primary determinant of insulin sensitivity, with AN scoring adding minimal clinical value.

Area of Science:

  • Pediatric Endocrinology
  • Metabolic Health
  • Diabetes Risk Assessment

Background:

  • Overweight Hispanic children with a family history of type 2 diabetes are at increased risk for insulin resistance.
  • Acanthosis nigricans (AN) is a clinical sign often associated with insulin resistance.

Purpose of the Study:

  • To determine if acanthosis nigricans (AN) presence is linked to insulin sensitivity (S(i)) independently of adiposity in Hispanic children.
  • To assess if AN severity scoring improves clinical estimation of insulin sensitivity beyond AN presence alone.

Main Methods:

  • 131 overweight Hispanic children (ages 8-13) with a family history of type 2 diabetes were studied.
  • Physical examination assessed AN presence, extent, texture, and combined score.
  • Insulin sensitivity (S(i)) was measured using the frequently sampled intravenous glucose tolerance test and minimal modeling.

Main Results:

  • Body Mass Index (BMI) was the primary predictor of S(i), explaining 41% of variance.
  • The presence of AN independently explained an additional 4% of S(i) variability.
  • AN scale scoring (extent or texture) did not significantly enhance S(i) prediction.

Conclusions:

  • AN is an independent risk factor for insulin resistance in this population, but adiposity is the main driver of S(i).
  • Clinical assessment of AN severity through scale scoring offers minimal added value for estimating insulin resistance beyond BMI and AN presence.
Abstract

Related Concept Videos

Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...